BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24968698)

  • 21. miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias.
    Malik D; Kaul D; Chauhan N; Marwaha RK
    Mol Cancer; 2014 Jul; 13():175. PubMed ID: 25037230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
    Quentmeier H; Schneider B; Röhrs S; Romani J; Zaborski M; Macleod RA; Drexler HG
    J Hematol Oncol; 2009 Jan; 2():3. PubMed ID: 19166587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of leukemias with ETV6-ABL1 fusion.
    Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
    Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical Considerations for Using RNA Sequencing in Management of B-Lymphoblastic Leukemia: Malaysia-Singapore Acute Lymphoblastic Leukemia 2020 Implementation Strategy.
    Ni Chin WH; Li Z; Jiang N; Lim EH; Suang Lim JY; Lu Y; Chiew KH; Yin Kham SK; Zhi Oh BL; Tan AM; Ariffin H; Yang JJ; Eng-Juh Yeoh A
    J Mol Diagn; 2021 Oct; 23(10):1359-1372. PubMed ID: 34365011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
    Becker H; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Margeson D; Whitman SP; Wu YZ; Schwind S; Paschka P; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD
    J Clin Oncol; 2010 Feb; 28(4):596-604. PubMed ID: 20026798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
    Feng J; Li Y; Jia Y; Fang Q; Gong X; Dong X; Ru K; Li Q; Zhao X; Liu K; Wang M; Tian Z; Jia Y; Wang Y; Lin D; Wei H; Tang K; Mi Y; Wang J
    J Hematol Oncol; 2017 Feb; 10(1):61. PubMed ID: 28245838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
    Chung C; Ma H
    Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetics of acute lymphoblastic leukemia.
    Teitell MA; Pandolfi PP
    Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization.
    Heesch S; Neumann M; Schwartz S; Bartram I; Schlee C; Burmeister T; Hänel M; Ganser A; Heuser M; Wendtner CM; Berdel WE; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Ann Hematol; 2013 Jun; 92(6):747-58. PubMed ID: 23412561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia.
    Huang Q; Snyder DS; Chu P; Gaal KK; Chang KL; Weiss LM
    Leukemia; 2011 Feb; 25(2):371-5. PubMed ID: 21304535
    [No Abstract]   [Full Text] [Related]  

  • 32. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
    Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
    Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.
    Mets E; Van Peer G; Van der Meulen J; Boice M; Taghon T; Goossens S; Mestdagh P; Benoit Y; De Moerloose B; Van Roy N; Poppe B; Vandesompele J; Wendel HG; Van Vlierberghe P; Speleman F; Rondou P
    Haematologica; 2014 Aug; 99(8):1326-33. PubMed ID: 24895337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of BRAF V600E mutation in hematologic malignancies excluding hairy-cell leukemia.
    Ping N; Wang Q; Wang Q; Dong S; Wu L; Xue Y; Ruan C; Wu D; Chen S
    Leuk Lymphoma; 2012 Dec; 53(12):2498-9. PubMed ID: 22639828
    [No Abstract]   [Full Text] [Related]  

  • 35. Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12).
    Nakamura F; Seo S; Nannya Y; Ayabe R; Takahashi W; Handa T; Arai H; Iso H; Nakamura Y; Nakamura Y; Sasaki K; Ichikawa M; Imai Y; Ogawa S; Mitani K
    Int J Hematol; 2023 Sep; 118(3):388-393. PubMed ID: 36930401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: a study of 7 patients and review of the literature.
    De Braekeleer E; Meyer C; Douet-Guilbert N; Morel F; Le Bris MJ; Berthou C; Arnaud B; Marschalek R; Férec C; De Braekeleer M
    Blood Cells Mol Dis; 2010 Apr; 44(4):268-74. PubMed ID: 20206559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lineage switch from NPM1-mutant acute myeloid leukemia to acute T-cell lymphoblastic leukemia with KMT2D and ARID2 mutant.
    Chen Y; Wang L; Ren F; Zhang Y; Li J; Li G; Chang J; Tan Y; Chen X; Xu Z; Wang H
    Int J Lab Hematol; 2021 Aug; 43(4):O230-O233. PubMed ID: 33881803
    [No Abstract]   [Full Text] [Related]  

  • 38. MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.
    Gębarowska K; Mroczek A; Kowalczyk JR; Lejman M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223.
    Chiaretti S; Messina M; Tavolaro S; Zardo G; Elia L; Vitale A; Fatica A; Gorello P; Piciocchi A; Scappucci G; Bozzoni I; Fozza C; Candoni A; Guarini A; Foà R
    Haematologica; 2010 Jul; 95(7):1114-21. PubMed ID: 20418243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.